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 Introduction: IL-1β is one of the proinflammatory 
cytokines which is commonly found in various diseases, 
including Chronic Rhinosinusitis (CRS). It has been widely 
targeted as a therapeutic approach for inflammatory 
diseases. However, study of IL-1β expression and its 
correlation with CT-Scan grading scores in CRS is still 
scarce. Objective: To investigate IL-1β expression based 
on immunohistochemical examination and analyse its 
correlation with Lund-Mackay score in CRS with and 
without polyps. Method: This analytic observational study 
was done on 50 patients: 25 subjects in the CRS with 
Nasal Polyps (CRSwNP) group and 25 subjects in the 
CRS without Nasal Polyps (CRSsNP) group. The uncinate 
process was taken for immunohistochemical examination 
of IL-1β. Lund-Mackay score was calculated based on CT-
Scan of the paranasal sinus. Result: IL-1β expression in 
CRSsNP (mean=36.38) was significantly higher than that 
in the CRSwNP (mean=14.62) with p<0.001. Lund-
Mackay score in CRSwNP was higher (mean=35.22) 
compared to CRSnNP group (mean=15.78) with p<0.001. 
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Chronic rhinosinusitis (CRS) is often encountered in daily medical practice. The 
prevalence is quite varied, with an approximate incidence rate of 10.9% in Europe, 12% 
in America, 11% in South Korea, and 8% in China.1 This disease deserves special 
attention as it is associated with multi-factorial etiology and significant interference in 
quality of life which leads to substantial costs. Chronic rhinosinusitis can be divided into 
CRS with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP) which are 
distinguished from nasoendoscopy and CT-Scan. There are several criteria for the 
classification of rhinosinusitis based on CT scan images, one of them is “Lund-Mackay” 
scoring system. This system is more often used and recommended because it is 
uncomplicated and has a high sensitivity and specificity.2 
Cytokines play a major role in the pathophysiology of CRS. IL-1β is one of the cytokines 
which is found in the inflammatory process of CRS and plays a role in proliferation, 
differentiation, and pyroptosis.1, 3 During innate immunity, IL-1β activates T cells and 
monocytes, regulates the expression of number of cytokines and inflammatory proteins, 
thereby increasing transendothelial migration of eosinophils and recruitment of 
neutrophils, which results in clinical symptoms.4 
IL-1β is initially produced as an inactive precursor, termed pro IL-1β, in response to 
pathogen associated molecular patterns (PAMPs). Pro IL-1β is a pathogen-carrying 
molecule, which binds to pattern recognition receptors (PRRs) on macrophages in the 
sinonasal mucosa. Induced cells then encounter further PAMPs and danger associated 
molecular patterns (DAMPs), which are endogenous molecules released by dead cells, 
to induce the secretion of the active molecule IL-1β.5 Immunohistochemical examination 
can be utilized to visualize the distribution of IL-1β in the tissue by using an antigen-
antibody reaction. Currently, IL-1β blockage is developed as a therapeutic target for local 
and systemic inflammatory conditions.6 However, there are still few studies about IL-1β 
based on immunohistochemistry in CRS, especially those that assess its correlation with 
CT-Scan grading.  
2.  METHODS  
This study was a cross sectional with observational analytic model. Participants 
were obtained from the ENT polyclinic of Hasanuddin University hospital, Makassar, 
South Sulawesi, Indonesia. Subjects who met the criteria were asked to sign an informed 
consent before they were enrolled in this study. This research has met the requirements 
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There was a moderate negative correlation (-0.403) 
between IL-1β expression and Lund-Mackay score 
(p<0.05). Conclusion: There was a moderate negative 
correlation between IL-1β expression and Lund-Mackay 
score. The IL-1β and the Lund-Mackay score in CRSwNP 
were lower and higher, respectively, than in CRSsNP. 
 Copyright © 2021 NMSJ. All rights reserved. 





of the Research Ethics Commission of the Faculty of Medicine, Hasanuddin University 
with the recommendation of ethical approval number 688/UN4.6.4.5.31/PP36/2020 
Subjects whose complaints did not improve with adequate standard medical therapy 
were divided into two groups (CRSwNP and CRSsNP) and underwent Functional 
Endoscopic Sinus Surgery (FESS). Samples of the uncinate mucosa were fixated with 
10% neutral buffer formalin and processed at the anatomical pathology laboratory, 
Hasanuddin University Hospital, Makassar, South Sulawesi, Indonesia. The 
immunohistochemical examination procedure was carried out using IL-1β Monoclonal 
Antibody (Bioenzy). The Lund-Mackay score was calculated based on cross coronal CT-
Scan of the paranasal sinuses without contrast before the FESS procedure. The score 
range is 0-24 which was divided into two groups, score ≤12 and score >12. 
Data were analyzed with SPSS version 23 (SPSS Inc. Chicago, IL, USA). Mann-Whitney 
U-test with a significance level of <0.05 was used to examine the comparison of IL-1β 
expression and Lund-Mackay score between CRSwNP and CRSsNP groups. Spearman 
correlation test was conducted to see the correlation between IL-1β expression and 
Lund-Mackay score. 
3. RESULTS 
The total participants were 50 subjects which consisted of 25 CRSwNP patients 
and 25 CRSsNP patients. The majority of participants were women (31, 62%). The age 
group of 18-28 years was the most prevalent age group (20, 40%) followed by the 29-39 
years age group (13, 26%) while 40-50 years was the least commonly found age group 
(7, 14%). All participants complained of rhinorrhea and 62% did not report any smelling 
disorder. Most samples had moderate symptoms of nasal obstruction (22, 44%), 
rhinorrhea (36, 72%), and facial pain (27, 54%) (Table 1). 
Table 1. Distribution of age, gender, phenotype, and participant complaints 
Variable n (Total = 50) % 
Age (Years)   
 18-28  20  40 
 29-39  13  26 
 40-50  7  14 
 >50  10  20 
Sex   
 Woman 31  62 
Phenotype   
 CRS with polyps 25 50 
 CRS without polyps 25 50 





Complaint   
Nasal Obstruction   
 None 6  12 
 Mild 16  32 
 Moderate 22  44 
 Severe 6  12 
Rhinorrhea   
 None 0  0 
 Mild 1  2 
 Moderate 36  72 
 Severe 13 26 
Facial Pain   
 None 3  6 
 Mild 14  28 
 Moderate 27  54 
 Severe 6  12 
Smelling Disorder   
 None 31  62 
 Mild 12  24 
 Moderate 5  10 
 Severe 2  4 
 
IL-1β expression in the CRSwNP and CRSsNP groups 
The range of IL-1β expression in CRS with polyps is 4%–136% and the range of IL-1β 
expression in CRS without polyps was 56% – 95.6%. Table 2 showed differences in the 
mean of IL-1β expression in CRSwNP (14.62) and CRSsNP (36.38). This result showed 
that the expression of IL-1β in CRSsNP was significantly higher than in CRSwNP 
(p<0.05). Figure 1 depicted that IL-1β expressed in the uncinate mucosa of CRSwNP 
was fewer than in CRSsNP patiens. 






Figure 1. IL-1β expression shown by brown cells on immunohistochemical examination. IL-1β expressed in 
the uncinate mucosa of a). CRSwNP fewer than in b). CRSsNP patiens. The figure also shows that there 
are fewer inflammatory cells in CRSwNP than in CRSsNP 
Table 2. Expressions IL-1β in CRS with and without polyps 
CRS phenotype Min (%) Max (%) Mean P-value 
CRSwNP (n=25) 4 136 14.62 
<0.001 
CRSsNP (n=25) 56 95.6 36.38 
Analysis: Mann-Whitney U Test 
Lund-Mackay score in the CRSwNP and CRSsNP groups 
Table 3 shows that more than half of the sample (29, 58%) had a Lund-Mackay score ≤ 
12. However, there was a difference in Lund-Mackay score based on the CRS 
phenotype. Most of Lund-Mackay score in CRSwNP was >12 (72%) while in CRSsNP 
most of this score was ≤ 12 (88%). Table 4 shows the significant difference between the 
Lund-Mackay scores on CRSwNP and CRSsNP. The mean score of Lund-Mackay in 
CRSwNP (35.22) was higher with a score range of 5-24 compared to CRSsNP (15.78) 
with a score range of 2-21 (p < 0.05). 







Total (n = 50) 29 (58.0%) 21 (42.0%) 
<0.001 CRSwNP (n=25) 7 (28.0%) 18 (72.0%) 










Table 4. Analysis of Lund-Mackay Score in CRS with and without polyps 
CRS phenotype Min (%) Max (%) Mean P-value 
CRSwNP (n=25) 5 24 35.22 
<0.001 
CRSsNP (n=25) 2 21 15.78 
Analysis: Mann-Whitney U Test  
Analysis of the correlation between IL-1β expression and Lund-Mackay score in 
CRS with and without polyps 
The results showed that there was a significant correlation between the expression of IL-
1β with the Lund-Mackay score (p=0,004). Statistical analysis showed a negative 
correlation between the expression of IL-1β with the Lund-Mackay score with moderate 
correlation strength value (0.403). This means that the higher the IL-1β expression, the 
lower the Lund-Mackay score is (Table 5). 
Table 5. Expression Correlation of IL-1β and Lund-Mackay Score 
  LMK Score 
IL-1β  Correlation Coefficient –.403 
 Sig. (2-tailed) .004 
 N 50 
Analysis: Spearman Correlation Test 
4. DISCUSSIONS 
 
This study showed that most cases of CRS occurred in the productive age group 
of 18-28 years and in women. The incidence of CRS was more likely to occur in the 
young productive age group because they are more often exposed to environmental 
factors such as air pollution and cigarette smoke compared to other age groups. These 
environmental factors can damage the respiratory tract mucosa which ultimately 
interferes with the mucociliary clearance system. This is in accordance with a previous 
study conducted by Triola, S (2019) in Padang which received the most samples under 
40 years old at 71.43%. A different finding was seen in another study which reported that 
the highest incidence of CRS occurred in subjects above 40 years old (48.89%).7, 8 One 
theory postulates that estrogen affects with the state of the nasal mucosa. During 
hormonal instability, the vascularization of the nasal mucosa may be disrupted and 
results in cell damage, impaired oxygenation and impaired function of the nasal 
mucosa.(7) Another theory states that there are differences in response to medical 
therapy, where the anti-inflammatory effect of steroid drugs may be more effective in 
men.9 The European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) 2020 
suggests that microbial factors, environmental factors, and host factors such as allergies, 
immunodeficiency, anatomical abnormalities, mucociliary dysfunction, odontogens, and 





trauma have important roles in the incidence of CRS. This could explain the differences 
in the characteristics of age and sex in different regions.1 
Lund-Mackay Score, IL-1β Expression, and Their Correlation in Chronic 
Rhinosinusitis 
In this study, the Lund-Mackay score on the majority of subjects was ≤ 12. This finding 
was consistent with a study by Min et al with an average score of 6.83 and in contrast to 
Younis, et al (2016), where the average score obtained was 14.01. However, unlike in 
this study, both studies did not differentiate scores based on the CRS phenotype.8, 10 In 
CRSwNP, more score was >12 with a score range of 5-24 while in CRSsNP more score 
was ≤12 (88%) with a score range of 2-21. These results were in line with Savastano, et 
al (2014) who found the average score of CRSwNP was 18. Another study found that 
the average score of CRSsNP was 8 with a score range of 5-12.11, 12 The Lund-Mackay 
Score System was created to see the degree of inflammation of the paranasal sinuses 
and the presence of obstruction from ostiomeatal complex. 
The expression of IL-1β by all samples confirmed that IL-1β is a major proinflammatory 
cytokine in CRS. Infected nasal mucosa showed increased IL-1β expression and was 
associated with an increase in mucus production.13 The results of this study also showed 
a significant difference between IL-1β expression in CRSwNP and CRSsNP where the 
IL-1β expression in CRSsNP was higher compared to CRSwNP. This finding was 
different from Plewka, et al. who found that IL-1β was more common in CRSwNP. They 
also found that IL-1β was expressed in various layers of the nasal mucosa of CRS 
patients, most of which were in the stroma. The study found that the greatest difference 
in IL-1β expression between CRSwNP polyps and CRSsNP was found in the 
endothelium.14 Meanwhile, in this study, IL-1β expression was examined in the stroma. 
The differences of IL-1β expression could be due to the effect of oral steroid medication. 
Our sample who suffered from CRSwNP had received high-dose oral and intranasal 
corticosteroid, while the CRSsNP did not receive high-dose oral corticosteroid therapy. 
Previous study has stated that CRSwNP treated with steroids showed a decrease in 
NLR. This protein is known to form an inflamosome that produces IL-1β through the 
caspase-1 pathway.15 Saber A, et al also found that the expression of NLRP3, which 
plays a role in the production of IL-1β, was higher in CRSwNP. However, after 
administration of steroids there was a decrease in NLRP3 expression. A similar finding 
was also obtained in another study that showed a decreased  IL-1β expression following 
steroid administration for three months.16, 17 Langereis, et al conducted a study on the 
effects of steroids on the secretion of IL-1Ra and IL-1β and found that steroids work by 
suppressing the secretion of TNF-α which plays a role in pro IL-1β production which 
leads to a reduction in IL-1β excretion.18 
Based on EPOS 2020, the latest classification of CRS does not solely depend on polyp 
phenotypes and is instead classified into primary and secondary, which are further 
grouped based on anatomy and dominant endotype.1 Cytokines are not only the key 
regulator of cellular interactions but also as biomarkers of different endotypes.15 Thus, 





the expression of IL-1β based on the presence or absence of polyps is still not adequate 
to explain the pathogenesis of inflammation in CRS. In addition, proinflammatory 
cytokines that are involved in the incidence of CRS are not only IL-1β but also other 
cytokines that play a role in both innate and adaptive immunity.1 This might explain the 
results of this study where there was negative correlation with moderate strength 
between IL-1β expression and Lund-Mackay score on CRS. Research conducted by 
Min, et al (2015) found that there was no correlation between IL-1β and the Lund-Mackay 
score. However, the IL-1β identification method, which used ELISA from nasal rinse 
specimen, was different from the current study.8 The presence of IL-1β expression in this 
study outlined the involvement of this interleukin in the pathophysiology of CRS, 
rendering IL-1β to be a potential therapeutic target in CRS. 
5. CONCLUSION 
IL-1β was expressed in all CRS patients and was lower in CRSwNP than in 
CRSsNP and the Lund-Mackay score was higher in CRSwNP than in CRSsNP. There 
was a negative correlation with moderate strength between IL-1β expression and Lund-
Mackay score which was thought to be caused by steroid medication. 
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